PLUR

#4492
Pluri Inc. Common Stock
3.4600 USD
+1.76%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
3.4600
3.4600
Faixa anual
3.0100
3.8220
Mudança diária
+1.76%
Mudança mensal
+4.37%
Mudança em 6 meses
-9.47%
Mudança anual
-9.47%
Fechamento anterior
3.4000
Abrir
3.4600
Bid
Ask
Mínimo
3.4600
High
3.4600
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 34.7756 M
  • Employee 142
  • Founded 2001
  • CEO Yaky Yanay
  • Website www.pluri-biotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DQX509
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.9
Price to sales ratio
16.22

Pluri Inc

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

Notícias